TrialThe Lancet. Infectious diseases2017

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.

Martin J Boeree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.